Afficher la notice abrégée

dc.rights.licenseopenen_US
dc.contributor.authorFOREST, Valerie
dc.contributor.authorPOURCHEZ, Jeremie
dc.contributor.authorPELISSIER, Carole
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorAUDIGNON DURAND, Sabyne
dc.contributor.authorVERGNON, Jean Michel
dc.contributor.authorFONTANA, Luc
dc.date.accessioned2021-12-06T14:16:58Z
dc.date.available2021-12-06T14:16:58Z
dc.date.issued2021-08-30
dc.identifier.issn2305-6304 (Electronic) 2305-6304 (Linking)en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/123997
dc.description.abstractEnThe biomonitoring of nanoparticles in patients' broncho-alveolar lavages (BAL) could allow getting insights into the role of inhaled biopersistent nanoparticles in the etiology/development of some respiratory diseases. Our objective was to investigate the relationship between the biomonitoring of nanoparticles in BAL, interstitial lung diseases and occupational exposure to these particles released unintentionally. We analyzed data from a cohort of 100 patients suffering from lung diseases (NanoPI clinical trial, ClinicalTrials.gov Identifier: NCT02549248) and observed that most of the patients showed a high probability of exposure to airborne unintentionally released nanoparticles (>50%), suggesting a potential role of inhaled nanoparticles in lung physiopathology. Depending on the respiratory disease, the amount of patients likely exposed to unintentionally released nanoparticles was variable (e.g., from 88% for idiopathic pulmonary fibrosis to 54% for sarcoidosis). These findings are consistent with the previously performed mineralogical analyses of BAL samples that suggested (i) a role of titanium nanoparticles in idiopathic pulmonary fibrosis and (ii) a contribution of silica submicron particles to sarcoidosis. Further investigations are necessary to draw firm conclusions but these first results strengthen the array of presumptions on the contribution of some inhaled particles (from nano to submicron size) to some idiopathic lung diseases.
dc.language.isoENen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.subject.enBiomonitoring
dc.subject.enNanoparticles
dc.subject.enLung diseases
dc.subject.enMineralogical analysis of broncho-alveolar lavages
dc.subject.enOccupational exposure
dc.title.enRelationship between Occupational Exposure to Airborne Nanoparticles, Nanoparticle Lung Burden and Lung Diseases
dc.typeArticle de revueen_US
dc.identifier.doi10.3390/toxics9090204en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed34564355en_US
bordeaux.journalToxicsen_US
bordeaux.volume9en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - UMR 1219en_US
bordeaux.issue9en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.teamEPICENE_BPH
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.exportfalse
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Toxics&rft.date=2021-08-30&rft.volume=9&rft.issue=9&rft.eissn=2305-6304%20(Electronic)%202305-6304%20(Linking)&rft.issn=2305-6304%20(Electronic)%202305-6304%20(Linking)&rft.au=FOREST,%20Valerie&POURCHEZ,%20Jeremie&PELISSIER,%20Carole&AUDIGNON%20DURAND,%20Sabyne&VERGNON,%20Jean%20Michel&rft.genre=article


Fichier(s) constituant ce document

Thumbnail
Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée